Next Article in Journal
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis
Next Article in Special Issue
Aging with Down Syndrome—Where Are We Now and Where Are We Going?
Previous Article in Journal
In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
Previous Article in Special Issue
Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
 
 
Review

Article Versions Notes

J. Clin. Med. 2021, 10(19), 4582; https://doi.org/10.3390/jcm10194582
Action Date Notes Link
article xml file uploaded 3 October 2021 13:02 CEST Original file -
article xml uploaded. 3 October 2021 13:02 CEST Update -
article pdf uploaded. 3 October 2021 13:02 CEST Version of Record https://www.mdpi.com/2077-0383/10/19/4582/pdf-vor
article html file updated 3 October 2021 13:04 CEST Original file -
article xml file uploaded 10 October 2021 07:28 CEST Update -
article xml uploaded. 10 October 2021 07:28 CEST Update https://www.mdpi.com/2077-0383/10/19/4582/xml
article pdf uploaded. 10 October 2021 07:28 CEST Updated version of record https://www.mdpi.com/2077-0383/10/19/4582/pdf
article html file updated 10 October 2021 07:30 CEST Update -
article html file updated 30 July 2022 09:12 CEST Update https://www.mdpi.com/2077-0383/10/19/4582/html
Back to TopTop